NYSE:PRGO - Perrigo Stock Price, News, & Analysis

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Perrigo declared a quarterly dividend on Wednesday, October 31st. Investors of record on Friday, November 30th will be paid a dividend of $0.19 per share on Tuesday, December 18th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.16%. The ex-dividend date of this dividend is Thursday, November 29th. View Perrigo's Dividend History.

Perrigo Company PLC (NYSE:PRGO) released its quarterly earnings data on Thursday, November, 8th. The company reported $1.09 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.05 by $0.04. The company had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.17 billion. Perrigo had a return on equity of 11.32% and a net margin of 2.54%. The business's quarterly revenue was down 8.0% compared to the same quarter last year. During the same period last year, the business earned $1.39 EPS. View Perrigo's Earnings History.

Perrigo is scheduled to release their next quarterly earnings announcement on Thursday, March 7th 2019. View Earnings Estimates for Perrigo.

Perrigo issued an update on its FY18 earnings guidance on Thursday, November, 8th. The company provided earnings per share (EPS) guidance of $4.45-4.65 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.86. The company issued revenue guidance of ~$4.72 billion, compared to the consensus revenue estimate of $4.87 billion.Perrigo also updated its FY 2018 guidance to $4.45-4.65 EPS.

15 Wall Street analysts have issued 12-month price objectives for Perrigo's shares. Their predictions range from $63.00 to $110.00. On average, they anticipate Perrigo's stock price to reach $83.60 in the next twelve months. This suggests a possible upside of 27.8% from the stock's current price. View Analyst Price Targets for Perrigo.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 1 sell rating, 11 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Perrigo.

Press coverage about PRGO stock has trended somewhat positive this week, InfoTrie Sentiment reports. The research firm scores the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Perrigo earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future.

Some companies that are related to Perrigo include Takeda Pharmaceutical (TKPYY), ASTELLAS PHARMA/ADR (ALPMY), Alexion Pharmaceuticals (ALXN), Shiseido (SSDOY), Teva Pharmaceutical Industries (TEVA), Mylan (MYL), BioMarin Pharmaceutical (BMRN), UCB (UCBJF), Ono Pharmaceutical (OPHLF), GRIFOLS S A/S (GRFS), Merck KGaA (MKGAF), Bausch Health Companies (BHC), Genmab A/S (GNMSF), Jazz Pharmaceuticals (JAZZ) and Sarepta Therapeutics (SRPT).

Perrigo's stock is owned by a number of of retail and institutional investors. Top institutional investors include FMR LLC (8.10%), Franklin Resources Inc. (6.79%), BlackRock Inc. (6.08%), Victory Capital Management Inc. (2.29%), Ceredex Value Advisors LLC (2.07%) and Iridian Asset Management LLC CT (1.41%). Company insiders that own Perrigo stock include Geoffrey M Parker, Jeffrey C Smith, Jeffrey Needham, John Wesolowski, Judy L Brown, Murray S Kessler, Sharon Kochan, Svend Andersen, Thomas Farrington, Todd W Kingma and Uwe Roehrhoff. View Institutional Ownership Trends for Perrigo.

PRGO stock was sold by a variety of institutional investors in the last quarter, including Los Angeles Capital Management & Equity Research Inc., BlackRock Inc., Migdal Insurance & Financial Holdings Ltd., Crawford Investment Counsel Inc., Panagora Asset Management Inc., Mitsubishi UFJ Trust & Banking Corp, Bank of New York Mellon Corp and Prudential Financial Inc.. Company insiders that have sold Perrigo company stock in the last year include John Wesolowski, Thomas Farrington and Todd W Kingma. View Insider Buying and Selling for Perrigo.

PRGO stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Iridian Asset Management LLC CT, Ceredex Value Advisors LLC, Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management, First Eagle Investment Management LLC, Franklin Resources Inc., Victory Capital Management Inc. and Menora Mivtachim Holdings LTD.. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Jeffrey C Smith, John Wesolowski, Murray S Kessler, Svend Andersen, Todd W Kingma and Uwe Roehrhoff. View Insider Buying and Selling for Perrigo.

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PRGO stock can currently be purchased for approximately $65.39.

Perrigo has a market capitalization of $8.70 billion and generates $4.95 billion in revenue each year. The company earns $119.60 million in net income (profit) each year or $4.93 on an earnings per share basis. Perrigo employs 10,400 workers across the globe.

The official website for Perrigo is http://www.perrigo.com.

Perrigo's mailing address is TREASURY BUILDING LOWER GRAND CANAL STREET, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]